Researchers have demonstrated that remotely administered digital cognitive assessments can detect subtle cognitive decline associated with early Alzheimer’s disease (AD) within just 30 weeks, offering a potentially valuable tool for monitoring disease progression and evaluating interventions.
One of the major challenges in Alzheimer’s research is the slow progression of cognitive decline, which can make it difficult to measure meaningful changes over short periods using conventional assessments. To address this, investigators examined whether frequent, unsupervised cognitive testing performed remotely could identify early disease-related changes more rapidly.
The study included 202 adults aged 52–85 years who were enrolled in longitudinal observational studies. Of these, 152 participants were cognitively unimpaired (CU), while 50 had mild cognitive impairment (MCI), a condition often considered a precursor to dementia. Participants completed a series of self-administered digital memory tasks from home. These assessed several aspects of memory, including memory precision for objects and scenes, associative memory, and familiarity-dependent memory.
Cognitive Changes Detected in 30 Weeks
Over the 30-week study period, individuals with MCI experienced greater decline than cognitively unimpaired participants on the familiarity-dependent memory task. The researchers also examined the influence of beta-amyloid (Aβ), a key pathological hallmark of Alzheimer’s disease. Among participants with MCI who had available biomarker data, those who were Aβ-positive showed significantly greater deterioration than Aβ-negative individuals in both object memory precision and familiarity-dependent memory.
Importantly, changes detected through the remote familiarity-dependent memory task over 30 weeks were associated with cognitive decline measured through traditional annual in-person neuropsychological assessments conducted over several years. This finding suggests that the digital assessments capture clinically relevant changes that align with longer-term cognitive trajectories.
Implications for Alzheimer’s Monitoring
The results indicate that frequent remote cognitive testing may provide a sensitive and practical approach for identifying subtle cognitive decline in the earliest stages of Alzheimer’s disease. By enabling more rapid detection of change than conventional methods, such tools could help researchers evaluate treatment effects more efficiently and support earlier monitoring of individuals at risk of disease progression.
The authors conclude that unsupervised digital cognitive assessments represent a promising strategy for capturing short-term cognitive changes in early Alzheimer’s disease, with potential applications in both clinical research and future patient monitoring.
Reference
Polk S et al. Smartphone-based detection of subtle memory decline in prodromal Alzheimer’s disease. NPJ Digit Med. 2026;9:402.
Featured image: Natee Meepian on Adobe Stock
- Author:
